SCHEMBL5003607

SCHEMBL5003607

CCCSN[C@H](CS)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ THPO P40225 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ BLM P54132 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ACE P12821 4/20 0.43
▸ FOLH1 Q04609 1/20 0.37
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ MME P08473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4319218 1.00 KDM4E (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL4319221 1.00 KDM4E (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL6058015 0.89 KDM4E (0.44) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL8915722 0.89 KDM4E (0.44) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL10896691 0.87 MAPT (0.43) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL157552 0.84 KDM4E (0.50) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL2597732 0.84 KDM4E (0.50) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL2597731 0.84 KDM4E (0.50) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL4309161 0.82 KDM4E (0.44) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL4225527 0.82 KDM4E (0.44) KDM4EMAPTTHRBALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 — — US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 — — EP disclosed
EP-2511844-A2 Advanced drug development and manufacturing Los Alamos National Security, LLC (US) 2012-10-17 — — EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 — — EP disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 — — US disclosed
Send feedback